Literature DB >> 11064834

[Evaluation of the quality of life of schizophrenic patients: validation of the brief version of the Quality of Life Interview].

C Lancon1, P Auquier, R Launois, M Toumi, P M Llorca, P Bebbington, A Lehman.   

Abstract

UNLABELLED: The main objective of the study was to determine the psychometric properties (mainly, validity and reliability) of the French language version of the brief Quality of Life Interview (QoLI). That instrument evaluates both the subjective and objective aspects of quality of life.
METHODS: 128 patients fulfilling the DSM IV criteria for schizophrenia were included. Quality of life was evaluated using the brief QoLI. Schizophrenic symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS). The validity of the internal structure of the QoLI was investigated by means of item analysis, study of the correlations between the items and between the item-dimensions and principal component analysis addressing the subjective fields. The validity of the external structure was mainly investigated through the nomological validity study. The reliability of the scale was evaluated by studying the internal consistency. In addition, the acceptability of the scale was documented.
RESULTS: The results of the study of the validity of the internal structure confirmed the pertinence of the pre-defined fields, particularly the subjective fields. Only some of the subjective fields of the QoLI showed significant correlations with the PANSS sub-scales. The acceptability of the scale was satisfactory.
CONCLUSIONS: The psychometric properties of the French language version of the brief QoLI appeared satisfactory. The brief QoLi was shown to be an easily used instrument for assessment of the various objective and subjective aspects of the quality of life of schizophrenic patients.

Entities:  

Mesh:

Year:  2000        PMID: 11064834

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  7 in total

1.  Perceptions of health intervene in the relationship between psychiatric symptoms and quality of life for individuals in supportive housing.

Authors:  Jason Matejkowski; Sungkyu Lee; Benjamin Henwood; Jonathon Lukens; Lara Carson Weinstein
Journal:  J Behav Health Serv Res       Date:  2013-10       Impact factor: 1.505

2.  Ending homelessness among people with mental illness: the At Home/Chez Soi randomized trial of a Housing First intervention in Toronto.

Authors:  Stephen W Hwang; Vicky Stergiopoulos; Patricia O'Campo; Agnes Gozdzik
Journal:  BMC Public Health       Date:  2012-09-14       Impact factor: 3.295

3.  Vancouver At Home: pragmatic randomized trials investigating Housing First for homeless and mentally ill adults.

Authors:  Julian M Somers; Michelle L Patterson; Akm Moniruzzaman; Lauren Currie; Stefanie N Rezansoff; Anita Palepu; Karen Fryer
Journal:  Trials       Date:  2013-11-01       Impact factor: 2.279

4.  Brief case management versus usual care for frequent users of emergency departments: the Coordinated Access to Care from Hospital Emergency Departments (CATCH-ED) randomized controlled trial.

Authors:  Vicky Stergiopoulos; Agnes Gozdzik; Jason Tan de Bibiana; Tim Guimond; Stephen W Hwang; Donald A Wasylenki; Molyn Leszcz
Journal:  BMC Health Serv Res       Date:  2016-08-24       Impact factor: 2.655

5.  A Comprehensive Assessment to Enable Recovery of the Homeless: The HOP-TR Study.

Authors:  Coline Van Everdingen; Peter Bob Peerenboom; Koos Van Der Velden; Philippe A E G Delespaul
Journal:  Front Public Health       Date:  2021-07-09

6.  Housing First: exploring participants' early support needs.

Authors:  Vicky Stergiopoulos; Agnes Gozdzik; Patricia O'Campo; Alixandra R Holtby; Jeyagobi Jeyaratnam; Sam Tsemberis
Journal:  BMC Health Serv Res       Date:  2014-04-13       Impact factor: 2.655

Review 7.  Health related quality of life in patients having schizophrenia negative symptoms - a systematic review.

Authors:  Chiraz Azaiez; Aurélie Millier; Christophe Lançon; Emilie Clay; Pascal Auquier; Pierre-Michel Llorca; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2018-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.